• Silurian Pharmaceutical

    Translating Marine Biomedical Discoveries to Medicine

    Silurian's development platform is based on novel polyether compounds discovered from marine micro-organisms. Initially, Silurian will exploit the unique discovery of Brevenal, a ladder-frame polyether for pulmonary disorders.

  • Brevenal

    Brevenal was discovered in Karenia brevis, a dinoflagellate causing Red Tide in the Gulf of Mexico. Dinoflagellates first evolved during the Silurian geological period (443-416 million years ago).

  • Brevenal

    Brevenal is an inhaled compound for the relief of bronchoconstriction and mucus clearance for patients with cystic fibrosis and COPD. It reduces hyper-responsiveness by Inhibiting neutrophil elastase induced lung dysfunctions.

  • Brevenal

    Brevenal (C39H60O8; MW 656.4043) is manufactured from a proprietary strain of K. brevis in a biotechnology facility, under photosynthetic conditions. The compound is isolated from the cultured organism.

  • Silurian Pharmaceutical

    Translating Marine Biomedical Discoveries to Medicine

    Silurian's development platform is based on novel polyether compounds discovered from marine micro-organisms. Initially, Silurian will exploit the unique discovery of Brevenal, a ladder-frame polyether for pulmonary disorders.

  • Brevenal

    Brevenal was discovered in Karenia brevis, a dinoflagellate causing Red Tide in the Gulf of Mexico. Dinoflagellates first evolved during the Silurian geological period (443-416 million years ago).

  • Brevenal

    Brevenal is an inhaled compound for the relief of bronchoconstriction and mucus clearance for patients with cystic fibrosis and COPD. It reduces hyper-responsiveness by Inhibiting neutrophil elastase induced lung dysfunctions.

  • Brevenal

    Brevenal (C39H60O8; MW 656.4043) is manufactured from a proprietary strain of K. brevis in a biotechnology facility, under photosynthetic conditions. The compound is isolated from the cultured organism.